|
Mechanismfungal CYP51A1 inhibitors |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.- |
First Approval Date01 Jan 1988 |
100 Clinical Results associated with Hedgepath Pharmaceuticals
0 Patents (Medical) associated with Hedgepath Pharmaceuticals
100 Deals associated with Hedgepath Pharmaceuticals
100 Translational Medicine associated with Hedgepath Pharmaceuticals